A new case study is the latest to suggest that GLP-1 therapy can tamp down people's unhealthy cravings of drugs like alcohol ...

A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

Eli Lilly (LLY, Financial) is set to pivot its focus beyond obesity after a monumental windfall from its GLP-1 drugs. At its ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

Microdosing GLP-1 has been touted for everything for weight management to perimenopause symptoms. But is it all it’s cracked ...

RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

It’s not yet entirely clear why GLP-1 drugs help with addiction, but it may have to do with the overlap between the appetite circuits in the brain with the reward pathways involved in addiction ...

Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.

When I tell people I direct clinical research studies, I often encounter surprise. “Aren’t you a physician?” they ask. It ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.